News

Bladder cancer has one of the highest incidence rates in the world and ranks as the fourth most common tumour in men. Despite its relatively low mortality rate, nearly half of bladder tumours resurface within 5 years, requiring ongoing patient monitoring. Frequent hospital visits and

In the ever-evolving landscape of cancer treatment, recent breakthroughs in the fight against non-small cell lung cancer (NSCLC) have brought new hope to patients and clinicians alike. At the forefront of these advancements is the remarkable progress in understanding and targeting mutations in the epidermal

CA 15-3 is an epitope of the MUC1 glycoprotein. MUC1 is a transmembrane mucosa-associated glycoprotein and contains a large extracellular domain, a transmembrane region and a cytoplasmic tail. The extracellular portion of MUC1 consists of numerous tandemly repeating peptide sequences. These repeats lead to a

“Pazopanib is a multi-kinase inhibitor that is currently approved for treatment of advanced renal cell carcinoma and chemotherapy-refractory soft tissue sarcoma.” Credit: 2023 Gouda et al. “Pazopanib is a multi-kinase inhibitor that is currently approved for treatment of advanced renal cell carcinoma and chemotherapy-refractory soft

(MEMPHIS, Tenn. – January 11, 2024) Data from the St. Jude lifetime cohort study (St. Jude LIFE) revealed that two common biomarkers of cardiac function and damage could better predict cardiomyopathy within five years than routine clinical evaluations in high-risk, asymptomatic childhood cancer survivors. Early detection through

EL PASO, Texas (Jan. 11, 2024) – Researchers at The University of Texas at El Paso have identified a novel pharmaceutical compound that successfully kills leukemia and lymphoma cancer cells, potentially paving the way for new forms of therapy. Credit: The University of Texas at

(Memphis, Tenn – January 11th, 2024) Compared to adult cancers, pediatric cancers often have distinctive genetic causes. This means there is an opportunity to develop pediatric-focused diagnostic strategies and treatments. Research by St. Jude Children’s Research Hospital published today in Nature Genetics clarifies the genomic

Consistently breastfeeding infants in any amount during their first three months was associated with a lower risk of childhood obesity, regardless of the mother’s body mass index (BMI) before pregnancy, according to a new study funded by the Environmental influences on Child Health Outcomes (ECHO)

Extracts of a plant used in traditional medicine for centuries have shown anti-proliferative effects against breast cancer in an early-stage clinical trial.   Credit: Sarah Pack/MUSC Extracts of a plant used in traditional medicine for centuries have shown anti-proliferative effects against breast cancer in an early-stage

MIAMI, FLORIDA (EMBARGOED UNTIL JAN. 11, 2024, at 11 AM EST) – Certain cancers are more difficult to treat because they contain cells that are highly skilled at evading drugs or our immune systems by disguising themselves as healthy cells. Credit: Photo by Sylvester MIAMI,